• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Baxter to Host Third-Quarter 2024 Financial Results Conference Call for Investors

    10/16/24 4:15:00 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care
    Get the next $BAX alert in real time by email

    Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/391655054 to pre-register for the call and receive the call information.

    This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.

    About Baxter

    Every day, millions of patients and caregivers rely on Baxter's leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241016475593/en/

    Get the next $BAX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Q&A

    New
    • When will Baxter International Inc. host its conference call for third-quarter 2024 financial results?

      Baxter International Inc. will discuss its third-quarter 2024 financial results during a conference call on November 8, 2024.

    • How can individuals participate in the conference call?

      Participants can pre-register for the call by following the link provided in the announcement.

    • What time is the conference call scheduled to start?

      The conference call will take place at 7:30 a.m. Central Time.

    • Will the conference call be accessible via webcast?

      Yes, the call will be available via a webcast on Baxter's website.

    • What is the history and scope of operations for Baxter International Inc.?

      Baxter has been in operation for over 90 years, providing a wide range of healthcare products and solutions across more than 100 countries.

    Recent Analyst Ratings for
    $BAX

    DatePrice TargetRatingAnalyst
    2/26/2025$42.00Buy
    Goldman
    2/24/2025Hold → Buy
    Argus
    2/20/2025$39.00Overweight
    Barclays
    7/15/2024$39.00 → $30.00Equal-Weight → Underweight
    Morgan Stanley
    5/30/2024$36.00Neutral
    Goldman
    5/10/2024$40.00Buy → Hold
    TD Cowen
    5/30/2023$45.00Equal-Weight
    Morgan Stanley
    3/29/2023$43.00Neutral
    UBS
    More analyst ratings

    $BAX
    SEC Filings

    See more
    • Baxter International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation

      8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

      6/12/25 8:48:57 AM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by Baxter International Inc.

      SD - BAXTER INTERNATIONAL INC (0000010456) (Filer)

      5/29/25 4:16:13 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Baxter International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

      5/8/25 4:15:37 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care

    $BAX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • October 18, 2024 - FDA Roundup: October 18, 2024

      For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

      10/18/24 4:16:25 PM ET
      $NVCR
      $BAX
      Medical/Dental Instruments
      Health Care